⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8234548 | 0.78 | — | — | |
| SCHEMBL197668 | 0.71 | — | — | |
| SCHEMBL19595627 | 0.70 | — | — | |
| SCHEMBL4541324 | 0.68 | — | — | |
| SCHEMBL12448 | 0.67 | — | — | |
| SCHEMBL170862 | 0.67 | — | — | |
| SCHEMBL431384 | 0.67 | — | — | |
| SCHEMBL10184316 | 0.65 | — | — | |
| SCHEMBL6665645 | 0.65 | — | — | |
| SCHEMBL23642191 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3119854-B1 | LIQUID CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2020-02-05 | — | — | EP | disclosed |
| EP-3124475-A1 | QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS | Bristol-Myers Squibb Company (US) | 2017-02-01 | — | — | EP | disclosed |